Radiation therapy for neovascular age-related macular degeneration
Robert Petrarca, Timothy L JacksonDepartment of Ophthalmology, King’s College Hospital NHS Foundation Trust, London, UKAbstract: Antivascular endothelial growth factor (anti-VEGF) therapies represent the standard of care for most patients presenting with neovascular (wet) age-related m...
Main Authors: | Robert Petrarca, Timothy L Jackson |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-01-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/radiation-therapy-for-neovascular-age-related-macular-degeneration-a6027 |
Similar Items
-
Pipeline therapies for neovascular age related macular degeneration
by: Sruthi Arepalli, et al.
Published: (2021-10-01) -
Treatment of neovascular age-related macular degeneration: Current therapies
by: Albert J Augustin, et al.
Published: (2009-01-01) -
Experimental Models in Neovascular Age Related Macular Degeneration
by: Olivia Rastoin, et al.
Published: (2020-06-01) -
Progress in the treatment of neovascular age-related macular degeneration
by: Ya-Xin Wang, et al.
Published: (2021-10-01) -
Initial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration
by: Tryfon Rotsos, et al.
Published: (2010-11-01)